Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

John Hennessey, company founder and CEO: "During the past three years we've delivered nearly 30 F5's to clients all around ...

Glucotrack (GCTK) will participate in the FORGETDIABETES bionic pancreas initiative that will develop a long-term, automated insulin delivery ...

Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes studyRUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: ...

K Street is still digesting the 90-day pause on Trump’s so-called reciprocal tariffs to chart the best path forward for clients over the next three months.